Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Viatris Aims To Clear Up Investor ‘Disappointment’ After Breaking EBITDA Baseline
Company Also Reiterates $9bn Pre-Tax Proceeds Goal Via Divestments
Mar 10 2022
•
By
Dean Rudge
"Everything else" is competing with share buybacks • Source: Shutterstock
More from Strategy
More from Business